10/21/2026
🔬 Fabry Disease Research Opportunity!
ClearView Healthcare Partners is seeking to better understand the experiences and perspectives of people living with Fabry disease in the United States.
🔹The study welcomes adult and pediatric patients, males and females, and caregivers with experience with enzyme replacement therapy (ERT) and/or substrate reduction inhibitor (SRI) therapy.
🔹Participation involves a 60-minute telephone interview about diagnosis, symptoms, treatment experiences, sources of support, and thoughts on current and future therapies.
🔹Participation is voluntary, and responses will remain confidential. Eligible participants who complete the interview will receive $100 compensation.
Interested in participating or learning more? Contact Slater Hurst at [email protected].
Your voice and experiences can help inform a better understanding of life with Fabry disease!